Your browser doesn't support javascript.
loading
Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study.
Schmitz, E M H; Benoy-De Keuster, S; Meier, A J L; Scharnhorst, V; Traksel, R A M; Broeren, M A C; Derijks, L J J.
Afiliação
  • Schmitz EMH; Clinical Laboratory, Máxima Medical Center, Veldhoven, the Netherlands.
  • Benoy-De Keuster S; Expert Center Clinical Chemistry, Eindhoven, the Netherlands.
  • Meier AJL; Clinical Laboratory, Catharina Hospital, Eindhoven, the Netherlands.
  • Scharnhorst V; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • Traksel RAM; Department of Rheumatology, Máxima Medical Center, Eindhoven and Veldhoven, the Netherlands.
  • Broeren MAC; Department of Rheumatology, Máxima Medical Center, Eindhoven and Veldhoven, the Netherlands.
  • Derijks LJJ; Expert Center Clinical Chemistry, Eindhoven, the Netherlands.
Clin Rheumatol ; 36(9): 2129-2134, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28593609

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Reumáticas / Monitoramento de Medicamentos / Antirreumáticos / Medicamentos Biossimilares / Infliximab Tipo de estudo: Etiology_studies / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Reumáticas / Monitoramento de Medicamentos / Antirreumáticos / Medicamentos Biossimilares / Infliximab Tipo de estudo: Etiology_studies / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article